← All news

FROM THE NEWS FEED

Enveric Biosciences Announces Positive Results from Recently Completed IND-enabling ADMET Studies

2026-10-21 • Psychedelic Invest

Article summary

CAMBRIDGE, Mass., October 21, 2026--Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address…

Continue to the original publication for the complete article.